Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 7, 2003, Pages 771-774

  Carroll, William R ^a,c   Rosenstiel, David ^a   Fix, Jobe R ^b   De la Torre, Jorge ^b   Solomon, Joel S ^b   Brodish, Brian ^a   Rosenthal, Eben L ^a   Heinz, Tad ^b   Niwas, Santosh ^a   Peters, Glenn E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Kentucky   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN;

ARTICLE; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FISTULA; FREE TISSUE GRAFT; HEAD CANCER; HUMAN; LONG TERM CARE; NECK CANCER; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLINDAMYCIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL FLAPS; SURGICAL WOUND INFECTION;

EID: 0037827098     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.7.771     Document Type: Article

References (12)

1. Johnson JT, Yu VL. Antibiotic use during major head and neck surgery. Ann Surg. 1988;207:108-111.
2. Becker GD, Parrell GT. Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol. 1979;88:183-186.
3. Johnson JT, Schuller DE, Silver F, et al. Antibiotic prophylaxis in high-risk head and neck surgery: one-day vs. five-day therapy. Otolaryngol Head Neck Surg. 1986;95:554-557.
4. Mustafa E, Tashin A. Cefotaxime prophylaxis in major non-contaminated head and neck surgery: one-day vs. seven-day therapy. J Laryngol Otol. 1993;107: 30-32.
5. Johnson JT, Wagner RL, Schuller DE, Gluckman J, Suen JY, Snyderman NL. Prophylactic antibiotics for head and neck surgery with flap reconstruction. Arch Otolaryngol Head Neck Surg. 1992;118:488-490.
6. Girod DA, McCulloch TM, Tsue TT, Weymuller EA. Risk factors for complications in clean contaminated head and neck surgical procedures. Head Neck. 1995; 17:7-13.
7. Robbins KT, Favrot S, Hanna D, Cole R. Risk of wound infection in patients with head and neck cancer. Head Neck. 1990;12:143-148.
8. Friedman M, Venkatesan TK, Yakovlev A, Lem JW, Tanyeri HM, Caldarelli DD. Early detection and treatment of postoperative pharyngocutaneous fistula. Otolaryngol Head Neck Surg. 1999;121:378-380.
9. Mullholland S, Boyd JB, McCabe S, et al. Recipient vessels in head and neck microsurgery: radiation effect and vessel access. Plast Reconstr Surg. 1993;92: 628-632.
10. McLean NR, Ellis H. Does remote sepsis influence the patency rate of microvascular anastomoses? Br J Plast Surg. 1988;41:395-398.
11. Simons JP, Johnson JT, Yu VL, et al. The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction. Laryngoscope. 2001;111:329-335.
12. Weber RS, Raad I, Frankenthaler R, et al. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. Arch Otolaryngol Head Neck Surg. 1992; 118:1159-1163.